All In Biotech

Free tool

FAERS Monitor: Exparel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022496 or its brand name (Exparel, Bupivacaine). Reports on generic versions are filed under their own applications.

Reports

9,403

Serious

7,042

75% of reports

Hospitalization

2,776

Death reported

592

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use905
  • pain772
  • drug ineffective736
  • hypotension548
  • nausea414
  • hypoaesthesia381
  • maternal exposure during pregnancy379
  • exposure during pregnancy336
  • drug withdrawal syndrome281
  • vomiting275
  • maternal exposure during delivery258
  • labelled drug-drug interaction medication error250
  • overdose235
  • foetal exposure during pregnancy229
  • dyspnoea217

Reports by year received

View as table
YearReports
2004182
2005132
2006187
2007152
2008206
2009224
20106
201111
2012135
2013394
2014398
2015294
2016614
2017657
2018646
2019772
2020912
2021631
2022683
2023675
2024543
2025648
2026301

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,756 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
maternal exposure during deliverySignal258787.8684.5149,373
labelled drug-drug interaction medication errorSignal25065.157.515,268
exposure during pregnancySignal33612.210.93,419
maternal exposure during pregnancySignal3799.58.62,892
drug withdrawal syndromeSignal2817.26.41,491
foetal exposure during pregnancySignal2296.35.61,021
hypotensionSignal5486.15.62,361
hypoaesthesiaSignal3815.75.21,481
painSignal7722.82.6926
overdoseSignal2352.42.1200
off label useSignal9052.32.2702
vomiting2751.31.220
drug ineffective7361.21.239
nausea4141.21.110
dyspnoea2170.90.85

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.